Therapeutic area
  • Diagnostics

What the technology does

Polymerases capable of processing unnatural, xeno-nucleic acid (XNA) : alternative genetic polymers not found in nature

Advantage

Polymerases with the ability to process unnatural nucleic acids have been selected and evolved using a proprietary in vitro evolution technology, providing the tools to process a range of XNAs including ANA, FANA, CeNA, PNA and HNA.

Main application field

Various enzymes are available for processing of XNA, providing the tools for performance of selection and evolution of XNA aptamers with properties advantageous for diagnostic and therapeutic development

Usage

R&D tool

Status

Technology ready for evaluation and licensing

Intellectual Property

Patents filed 14-04-2011 (PCT/GB2011/000583), and 19-04-2012 (PCT/GB2013/050991).

Offering

Non-exclusive licence

  • In submitting your personal data via this form, you consent to being contacted via the details provided so that your enquiry can be responded to. A backup of your data will be held but only authorised individuals will be able to access your data. If you would like your data to be removed, please email support@thewebkitchen.co.uk.
    Please see our Privacy policy in relation to the personal data you submit to us through this page.
  • We would love to send you information about LifeArc news and events. Please let us know if you would like us to contact you by selecting one of the following options:
All Licensing Opportunities